Evidence map›Paper›PMID 33846417›Full record

ArticleScientific reports2021

Vagal control of the heart decreases during increasing imminence of interoceptive threat in patients with panic disorder and agoraphobia.

Jan Richter, Anne Pietzner, Julian Koenig, Julian F Thayer, Christiane A Pané-Farré, Alexander L Gerlach, Andrew T Gloster, Hans-Ulrich Wittchen, Thomas Lang, Georg W Alpers and 8 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 14 institutions in 3 countries.

Jan RichterDepartment of Biological and Clinical Psychology, University of Greifswald, Franz-Mehring-Str. 47, 17487, Greifswald, Germany. jan.richter@uni-greifswald.de.
Anne PietznerDepartment of Biological and Clinical Psychology, University of Greifswald, Franz-Mehring-Str. 47, 17487, Greifswald, Germany.
Julian KoenigSection for Experimental Child and Adolescent Psychiatry, Department of Child and Adolescent Psychiatry, Centre for Psychosocial Medicine, Heidelberg University, Heidelberg, Germany.
Julian F ThayerDepartment of Psychological Science, University of California, Irvine, Irvine, USA.
Christiane A Pané-FarréDepartment of Biological and Clinical Psychology, University of Greifswald, Franz-Mehring-Str. 47, 17487, Greifswald, Germany.
Alexander L GerlachClinical Psychology and Psychotherapy, University of Cologne, Cologne, Germany.
Andrew T GlosterDepartment of Psychology, Division of Clinical Psychology and Intervention Science, University of Basel, Basel, Switzerland.
Hans-Ulrich WittchenDepartment of Psychiatry & Psychotherapy, Ludwig-Maximilians-Universität Munich, Munich, Germany.
Thomas LangChristoph-Dornier-Foundation for Clinical Psychology, Institute for Clinical Psychology Bremen, Bremen, Germany.
Georg W AlpersDepartment of Psychology, School of Social Sciences, University of Mannheim, Mannheim, Germany.
Sylvia Helbig-LangDepartment of Psychology and Psychotherapy, University of Hamburg, Hamburg, Germany.
Jürgen DeckertDepartment of Psychiatry, Psychosomatic Medicine and Psychotherapy, University of Würzburg, Würzburg, Germany.
Thomas FydrichDepartment of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany.
Lydia FehmDepartment of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany.
Andreas StröhleDepartment of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Tilo KircherDepartment of Psychiatry and Psychotherapy, University of Marburg, Marburg, Germany.
Volker AroltDepartment of Psychiatry and Psychotherapy, University of Münster, Münster, Germany.
Alfons O HammDepartment of Biological and Clinical Psychology, University of Greifswald, Franz-Mehring-Str. 47, 17487, Greifswald, Germany.
Universität Greifswald · DEHumboldt-Universität zu Berlin · DECharité - Universitätsmedizin Berlin · DEConstructor University · DELudwig-Maximilians-Universität München · DEPhilipps University of Marburg · DEUniversität Hamburg · DEUniversity of Basel · CHUniversity of Bern · CHUniversity of California, Irvine · USUniversity of Cologne · DEUniversity of Mannheim · DEUniversity of Münster · DEUniversity of Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Theoretically, panic disorder and agoraphobia pathology can be conceptualized as a cascade of dynamically changing defensive responses to threat cues from inside the body. Guided by this trans-diagnostic model we tested the interaction between defensive activation and vagal control as a marker of prefrontal inhibition of subcortical defensive activation. We investigated ultra-short-term changes of vagally controlled high frequency heart rate variability (HRV) during a standardized threat challenge (entrapment) in n = 232 patients with panic disorder and agoraphobia, and its interaction with various indices of defensive activation. We found a strong inverse relationship between HRV and heart rate during threat, which was stronger at the beginning of exposure. Patients with a strong increase in heart rate showed a deactivation of prefrontal vagal control while patients showing less heart rate acceleration showed an increase in vagal control. Moreover, vagal control collapsed in case of imminent threat, i.e., when body symptoms increase and seem to get out of control. In these cases of defensive action patients either fled from the situation or experienced a panic attack. Active avoidance, panic attacks, and increased sympathetic arousal are associated with an inability to maintain vagal control over the heart suggesting that teaching such regulation strategies during exposure treatment might be helpful to keep prefrontal control, particularly during the transition zone from post-encounter to circa strike defense.Trial Registration Number: ISRCTN80046034.

Indexed as

Acute DiseaseAdultAgoraphobiaFemaleHeart RateHumansMalePanic DisorderTime FactorsVagus Nerve

Identifiers

PMID33846417
PMCPMC8041829
OpenAlexW3156044528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.